共 131 条
- [1] Bridgeman MB(2017)Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting P T 42 180-188
- [2] Abazia DT(2018)Cannabinoids and Pain: New Insights From Old Molecules Front Pharmacol 9 1259-259
- [3] Vučković S(2008)Cannabinoids in the management of difficult to treat pain Ther Clin Risk Manag. 4 245-83
- [4] Srebro D(2007)The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain Eur J Pharmacol 556 75-1068
- [5] Vujović KS(2001)Pharmacological actions and therapeutic uses of cannabis and cannabinoids Anaesthesia. 56 1059-462
- [6] Vučetić Č(2006)The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev. 58 389-266
- [7] Prostran M(2018)Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System Int J Mol Sci 19 833-4805
- [8] Russo EB(2009)Targeting CB2 receptors and the endocannabinoid system for the treatment of pain Brain Res Rev. 60 255-948
- [9] Costa B(2015)Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor Br J Pharmacol. 172 4790-2451
- [10] Trovato AE(2016)Westlund KNet al. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis Eur J Pain. 20 936-9566